Kefir-derived exopolysaccharide ameliorates hyperglycemic control and beta cell integrity in a rat model of type 2 diabetes mellitus - Yen, Chih-Ching; Tsai, Chung-Liang; Chang, Gary Ro-Lin; Ko, Chi-Hua; Tu, Min-Yu; Lan, Ying-Wei; Chen, Hsiao-Ling; Chen, Chuan-Mu (Nutrition & diabetes, 2025)
Keywords: 13/51; 631/1647/767/1424; 631/443/319/1642/137/773; 692/699/2743/137/773; 82/51; 82/80; 96/95; Animals; Antibodies; Blood Glucose - drug effects; Blood Glucose - metabolism; Cholesterol; Clinical Nutrition; Diabetes; Diabetes Mellitus, Experimental - drug therapy; Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - drug therapy; Diet; Diet, High-Fat - adverse effects; Epidemiology; Fermentation; Glucose; Glucose Transporter Type 2 - metabolism; High density lipoprotein; Hyperglycemia - drug therapy; Insulin - blood; Insulin resistance; Insulin-Secreting Cells - drug effects; Insulin-Secreting Cells - metabolism; Internal Medicine; Kefir; Kidneys; Kinases; Laboratories; Lipoproteins; Liver - drug effects; Liver - metabolism; Male; Medicine; Medicine & Public Health; Metabolic Diseases; Molecular weight; Polysaccharides - pharmacology; Polysaccharides - therapeutic use; Rats; Rats, Sprague-Dawley; Streptozocin; United States--US; Taiwan